Literature DB >> 9624156

Solution structure and main chain dynamics of the regulatory domain (Residues 1-91) of human cardiac troponin C.

K Pääkkönen1, A Annila, T Sorsa, P Pollesello, C Tilgmann, I Kilpeläinen, P Karisola, I Ulmanen, T Drakenberg.   

Abstract

The three-dimensional structure of calcium-loaded regulatory, i.e. N-terminal, domain (1-91) of human cardiac troponin C (cNTnC) was determined by NMR in water/trifluoroethanol (91:9 v/v) solution. The single-calcium-loaded cardiac regulatory domain is in a "closed" conformation with comparatively little exposed hydrophobic surface. Difference distance matrices computed from the families of Ca2+-cNTnC, the apo and two-calcium forms of the skeletal TnC (sNTnC) structures reveal similar relative orientations for the N, A, and D helices. The B and C helices are closer to the NAD framework in Ca2+-cNTnC and in apo-sNTnC than in 2.Ca2+-sNTnC. However, there is an indication of a conformational exchange based on broad 15N resonances for several amino acids measured at several temperatures. A majority of the amides in the alpha-helices and in the calcium binding loop exhibit very fast motions with comparatively small amplitudes according to the Lipari-Szabo model. A few residues at the N and C termini are flexible. Data were recorded from nonlabeled and 15N-labeled samples, and backbone dynamics was investigated by 15N T1, T2, and heteronuclear nuclear Overhauser effect as well as by relaxation interference measurements.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624156     DOI: 10.1074/jbc.273.25.15633

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Structural based insights into the role of troponin in cardiac muscle pathophysiology.

Authors:  Monica X Li; Xu Wang; Brian D Sykes
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

2.  Observation of microsecond time-scale protein dynamics in the presence of Ln3+ ions: application to the N-terminal domain of cardiac troponin C.

Authors:  Christian Eichmüller; Nikolai R Skrynnikov
Journal:  J Biomol NMR       Date:  2006-12-19       Impact factor: 2.835

3.  A new amide proton R1rho experiment permits accurate characterization of microsecond time-scale conformational exchange.

Authors:  Christian Eichmüller; Nikolai R Skrynnikov
Journal:  J Biomol NMR       Date:  2005-08       Impact factor: 2.835

Review 4.  The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.

Authors:  Tia Sorsa; Piero Pollesello; R John Solaro
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

5.  Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.

Authors:  Henry G Zot; Javier E Hasbun; Clara A Michell; Maicon Landim-Vieira; Jose R Pinto
Journal:  Arch Biochem Biophys       Date:  2016-03-11       Impact factor: 4.013

6.  The effect of the cosolvent trifluoroethanol on a tryptophan side chain orientation in the hydrophobic core of troponin C.

Authors:  Olivier Julien; Pascal Mercier; Melissa L Crane; Brian D Sykes
Journal:  Protein Sci       Date:  2009-06       Impact factor: 6.725

7.  Ca2+-induced PRE-NMR changes in the troponin complex reveal the possessive nature of the cardiac isoform for its regulatory switch.

Authors:  Nicole M Cordina; Chu K Liew; Phani R Potluri; Paul M Curmi; Piotr G Fajer; Timothy M Logan; Joel P Mackay; Louise J Brown
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  Calcium induced regulation of skeletal troponin--computational insights from molecular dynamics simulations.

Authors:  Georgi Z Genchev; Tomoyoshi Kobayashi; Hui Lu
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

9.  Structure of the inhibitor W7 bound to the regulatory domain of cardiac troponin C.

Authors:  Ryan M B Hoffman; Brian D Sykes
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

10.  Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice.

Authors:  Fabio Guarracino; Matthias Heringlake; Bernard Cholley; Dominique Bettex; Stefaan Bouchez; Vladimir V Lomivorotov; Angela Rajek; Matti Kivikko; Piero Pollesello
Journal:  J Cardiovasc Pharmacol       Date:  2018-01       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.